Trial Profile
Phase I trial investigating the tolerability of VX 702 in rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2009
Price :
$35
*
At a glance
- Drugs VX 702 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Vertex Pharmaceuticals
- 26 Sep 2009 New trial record.